Protocol for the CLOCKS study: A 4-arm randomized controlled trial testing the independent and combined effects of 2 chronotherapies—early time-restricted eating and daytime bright light therapy—in adults with type 2 diabetes
Nutrition Research · 2026-09 · 153 · 142-159
DOI: 10.1016/j.nutres.2026.07.006 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrition Research, 2026-09. Verfasst von Felicia L Steger und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL, USA; Division of Endocrinology, Diabetes, and Clinical Pharmac…. Hauptthemen laut MEDLINE: Chronotherapy, Circadian Rhythm, Diabetes Mellitus, Type 2, Intermittent Fasting. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 115 Literaturangaben. Gefördert von: NIDDK NIH HHS, US Department of the Army, National Institute of Diabetes and Digestive and Kidney Diseases.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Disruption of circadian rhythms worsens glycemic control and cardiovascular health. Conversely, evidence suggests that optimizing circadian rhythms by eating earlier in the day, practicing intermittent fasting, and/or getting sufficient sunlight or bright light during the daytime improves cardiometabolic health. Here, we describe the protocol for a 2 × 2 randomized controlled trial testing whether two chronotherapies-early time-restricted eating (eTRE) and/or daytime bright light therapy (BLT)-can improve glycemic control, diurnal rhythms, and overall health in adults with type 2 diabetes (T2D). We will randomize 344 adults with insulin-independent T2D to 1 of 4 groups: (1) control, (2) eTRE, (3) daytime BLT, or (4) eTRE + daytime BLT. Participants in the eTRE groups will eat within an 8-hour window ending by 17:00, while those in the BLT group will receive bright light for 90 min/day before 15:00 and use blue-light-blocking glasses and blackout curtains at night. The intensive phase of the intervention is 16 weeks, with follow-up at the 1-year mark. The primary outcome is glycemic control as measured by HbA1c and 24-hour glucose, supplemented by additional assessments of glucose metabolism. Secondary outcomes are the diurnal melatonin and cortisol rhythms and the diurnal variation in glucose uptake. Tertiary outcomes include body mass, body composition, resting energy expenditure, cardiovascular risk factors, sleep parameters, quality of life, and psychological health. To our knowledge, this is the largest study to date of TRE in people with T2D and the largest study to test whether daytime bright light therapy can improve cardiometabolic health. Trial Registration: This trial was registered at clinicaltrials.gov (NCT04155619).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL, USA; Division of Endocrinology, Diabetes, and Clinical Pharmacology, Department of Internal Medicine, University of Kansas Medical C…
- Department of Medicine, Samuel Oschin Comprehensive Cancer Center Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
- Department of Endocrinology, Birmingham Veterans Affairs Medical Center, Birmingham, AL, USA; Division of Endocrinology, Diabetes, and Metabolism, Heersink School of Medicine, University of Alabama at Birmingham, Birmin…
- Department of Health and Exercise Science, Colorado State University, Fort Collins, CO, USA.
- Division of Gastrointestinal Surgery, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.
- Department of Psychiatry and Behavioral Neurobiology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Förderung
- NIDDK NIH HHS
- US Department of the Army
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Steger, F. L., Salvy, S. J., Vaughan, T. B., Lowry, C., Richman, J. S., Gamble, K. L., Garvey, W. T., Scheer, F. A. J. L., & Peterson, C. M. (2026). Protocol for the CLOCKS study: A 4-arm randomized controlled trial testing the independent and combined effects of 2 chronotherapies—early time-restricted eating and daytime bright light therapy—in adults with type 2 diabetes. Nutrition Research, 153, 142-159. https://doi.org/10.1016/j.nutres.2026.07.006
Vancouver
Steger FL, Salvy SJ, Vaughan TB, Lowry C, Richman JS, Gamble KL, et al. Protocol for the CLOCKS study: A 4-arm randomized controlled trial testing the independent and combined effects of 2 chronotherapies—early time-restricted eating and daytime bright light therapy—in adults with type 2 diabetes. Nutrition Research. 2026;153:142-159. doi:10.1016/j.nutres.2026.07.006
BibTeX
@article{Steger2026,
author = {Steger, Felicia L and Salvy, Sarah-Jeanne and Vaughan, T Brooks and Lowry, Catherine and Richman, Joshua S and Gamble, Karen L and Garvey, W Timothy and Scheer, Frank A J L and Peterson, Courtney M},
title = {Protocol for the CLOCKS study: A 4-arm randomized controlled trial testing the independent and combined effects of 2 chronotherapies—early time-restricted eating and daytime bright light therapy—in adults with type 2 diabetes},
journal = {Nutrition Research},
year = {2026},
volume = {153},
pages = {142--159},
doi = {10.1016/j.nutres.2026.07.006}
}
EUVIMED